Zhongyuan Union Stem Cell Bio-engineering Corporation provided preliminary earnings guidance for the full year 2014. The company predicts a net profit owned by shareholders of listed company in 2014 to be about RMB 37 million, with an increase of about 412.77% compared with 2013 and the earnings per share being about RMB 0.10.